Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin exposure is associated with reduced development of acute-on-chronic liver failure in a Veterans Affairs cohort
Nadim Mahmud, Sara E. Chapin, David S. Goldberg, et al.
Journal of Hepatology (2022) Vol. 76, Iss. 5, pp. 1100-1108
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC
Suzanne R. Sharpton, Rohit Loomba
Hepatology (2023) Vol. 78, Iss. 6, pp. 1896-1906
Open Access | Times Cited: 26
A Systematic Review of Statins for the Treatment of Nonalcoholic Steatohepatitis: Safety, Efficacy, and Mechanism of Action
Shiqin Zhang, Xiaoling Ren, Bingzheng Zhang, et al.
Molecules (2024) Vol. 29, Iss. 8, pp. 1859-1859
Open Access | Times Cited: 12
Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers
Jonel Trebicka, Rubén Hernáez, Debbie L. Shawcross, et al.
Gut (2024) Vol. 73, Iss. 6, pp. 1015-1024
Open Access | Times Cited: 11
Early Diagnosis and Prevention of Infections in Cirrhosis
Anand V. Kulkarni, Madhumita Premkumar, Juan Pablo Arab, et al.
Seminars in Liver Disease (2022) Vol. 42, Iss. 03, pp. 293-312
Open Access | Times Cited: 29
Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
Rakesh Kumar Jagdish, Akash Roy, Karan Kumar, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 16
Current challenges and future perspectives in treating patients with NAFLD-related cirrhosis
Maxime Mallet, Cristina Alina Silaghi, Philippe Sultanik, et al.
Hepatology (2023) Vol. 80, Iss. 5, pp. 1270-1290
Closed Access | Times Cited: 14
Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
Thit Mynster Kronborg, Robert Schierwagen, Kajetan Trošt, et al.
Hepatology Communications (2023) Vol. 7, Iss. 12
Open Access | Times Cited: 13
Potential therapies for acute‐on‐chronic liver failure
Maura A. Morrison, Florent Artru, Francesca M. Trovato, et al.
Liver International (2023)
Open Access | Times Cited: 11
Acute-on-Chronic Liver Failure: Steps Towards Consensus
Loredana Gabriela Goran, Florina Alexandra Liță, Carmen Fierbințeanu‐Braticevici
Diagnostics (2025) Vol. 15, Iss. 6, pp. 751-751
Open Access
Hyperbilirubinemia at hospitalization predicts nosocomial infection in decompensated cirrhosis: Data from ATTIRE trial
Harriett Fuller, Thaís Tittanegro, Alexander A. Maini, et al.
Hepatology Communications (2025) Vol. 9, Iss. 4
Open Access
Liver Transplantation in Acute-on-Chronic Liver Failure
Anand V. Kulkarni, K. Rajender Reddy
Clinics in Liver Disease (2023) Vol. 27, Iss. 3, pp. 735-762
Closed Access | Times Cited: 9
Review of the role of statins in cirrhosis and portal hypertension
Jordi Gratacós‐Ginès, Elisa Pose
Clinical Liver Disease (2023) Vol. 22, Iss. 2, pp. 50-57
Open Access | Times Cited: 8
Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges
Markus Kimmann, Jonel Trebicka
Journal of Personalized Medicine (2023) Vol. 13, Iss. 7, pp. 1052-1052
Open Access | Times Cited: 5
The Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
Ji Eun Han, Jisu Kim, Jae Youn Cheong, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 249-249
Open Access | Times Cited: 1
Statin use in cirrhosis and its association with incidence of portal vein thrombosis
Waseem Amjad, Z. Gordon Jiang, Michelle Lai
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 5, pp. 955-963
Closed Access | Times Cited: 1
Recurrent alcohol-associated hepatitis is common and is associated with increased mortality
Jordi Gratacós‐Ginès, Pilar Ruz-Zafra, Miriam Celada-Sendino, et al.
Hepatology (2024) Vol. 80, Iss. 3, pp. 621-632
Closed Access | Times Cited: 1
Type of Infection Is Associated with Prognosis in Acute-on-Chronic Liver Failure: A National Veterans Health Administration Study
Nadim Mahmud, K. Rajender Reddy, Tamar H. Taddei, et al.
Digestive Diseases and Sciences (2022) Vol. 68, Iss. 4, pp. 1632-1640
Closed Access | Times Cited: 6
Fatal hepatic failure following atorvastatin treatment: A case report
Huajun Wang, Shiyi Liu, Chenjie Zhou, et al.
Medicine (2023) Vol. 102, Iss. 19, pp. e33743-e33743
Open Access | Times Cited: 3
Rates, patterns, and predictors of specialty palliative care consultation among patients with acute-on-chronic liver failure
Arpan Patel, Anne M. Walling, Fasiha Kanwal, et al.
JHEP Reports (2023) Vol. 6, Iss. 2, pp. 100976-100976
Open Access | Times Cited: 3
Statins in Cirrhosis: Hope or Hype?
Lauren Shaffer, Nadim Mahmud
Journal of Clinical and Experimental Hepatology (2023) Vol. 13, Iss. 6, pp. 1032-1046
Open Access | Times Cited: 2
Impact of Statins on the Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib or Lenvatinib
Hyo Jung Cho, Ji Eun Han, Jisu Kim, et al.
(2023)
Open Access | Times Cited: 2
The Role of Statins in Cirrhosis
Carlos Moctezuma‐Velázquez, Juan G. Abraldeṣ
Current Treatment Options in Gastroenterology (2022) Vol. 20, Iss. 3, pp. 316-335
Closed Access | Times Cited: 3
Phenotyping Hepatic Immune-Related Adverse Events in the Setting of Immune Checkpoint Inhibitor Therapy
Theodore C. Feldman, David E. Kaplan, Albert Y. Lin, et al.
JCO Clinical Cancer Informatics (2024), Iss. 8
Open Access
Association between statin exposure and short-term mortality in patients with high-grade acute-on-chronic liver failure
Sara E. Chapin, David E. Kaplan, Tamar H. Taddei, et al.
JHEP Reports (2023) Vol. 5, Iss. 6, pp. 100740-100740
Open Access | Times Cited: 1
Prevalence of Statin Use and Predictors of Statin Initiation Among Patients with Alcohol-Related Cirrhosis - A Danish Nationwide Cohort Study
Marine Sølling Ramsing, Frederik Kraglund, Peter Jepsen
Clinical Epidemiology (2023) Vol. Volume 15, pp. 435-446
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top